Johnson & Johnson Live Share Price Today, Share Analysis and Chart

Name: Johnson & Johnson: Is Infosys Ltd. worth buying?
Item: Johnson & Johnson
Rating: 2.569472375
Author: Trendlyne DVM scores

Mid-range Performer

about

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. Th...

156.90 -0.79 (-0.50%)

7.9M

XNYS Volume

XNYS 11 Jul, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Johnson & Johnson is on 17 Jul 2025 for the purpose of Johnson & Johnson Second Quarter Earnings Results for 2025 See details

High Financial Strength

55.6 / 100

Mid Valuation

39.2 / 100

Technically Neutral

55.3 / 100

Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM

169

1Yr Price target upside is 8%

23 analysts

Johnson & Johnson Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Johnson & Johnson Live Share Price Today, Share Analysis and Chart

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. Th...

SWOT Analysis

Johnson & Johnson Live Price Chart